Company / Capital Expenditures
Upstream Bio, Inc. Capital Expenditures History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$165.0K
FY2025
5-year range
$144.0K / $165.0K
FY2023-FY2025
Trend
+14.6%
vs FY2024
Sector context
#163 of 194
Health Care
What the data says
Upstream Bio, Inc.'s capital expenditures of $165,000 is lower than 84% of companies in the Health Care sector (FY2025). Improved from $144,000 to $165,000 over the past 2 years.
Based on SEC 10-K filings.
$165,000 in FY2025.
Improved from $144,000 to $165,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 194This company $165.0K Sector average $117.5M
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, capital expenditures increased 14.6% year-over-year.
- Ranks #163 out of 194 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 8.68 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $165.0K | +14.6% |
| FY2024 | $144.0K | +0.0% |
| FY2023 | $144.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026